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(maximum duration pending complete follow-up). Two patients
received the 200 units IA BoNT/A injection 8-12 weeks after the
first injection (including the only non-responder).
No increase in joint inflammation, periarticular muscle weakness,
fever or fatigue, or other complications were noted.
Conclusions: I/A BoNT/A significantly decreased refractory
prosthetic joint pain and appeared to be safe. A prospective
randomized trial is underway to confirm these findings.
P368
TRANEXAMIC ACID DECREASES BLOOD LOSS AND
LENGTH OF INPATIENT STAY IN PRIMARY HIP AND
KNEE ARTHROPLASTY
A.M. Imbuldeniya, C. Broomhead, T.M. Bucknill
The Royal London Hospital, London, United Kingdom
Purpose: There is no consensus regarding the optimal strategy
to minimise patients exposure to allogenic blood transfusion. The
majority of current literature suggests tranexamic acid reduces
blood loss following hip and knee arthroplasty.
The aim of this study is to determine whether these findings
are reproducible despite variations in surgical practice, whether
tranexamic acid has any effect on the length of inpatient stay
and whether there are any unwanted complications secondary
to administration.
Methods: Retrospective analysis of case notes.
Included all patients undergoing primary THR and TKR between
Jan 2005 to Dec 2005 under care of the senior author.
74 patients in total.
Aetiology was osteoarthritis in all cases.
Exclusions: Missing case notes 11, no documentation of blood
loss in drain 10
52 patients included in study
26 underwent primary TKR (13 had 1g i.v tranexamic acid
at induction and before release of tourniquet after cementing
prosthesis)
26 underwent primary THR (13 had 1g i.v tranexamic acid at
induction)
39 operated by senior surgeon
13 operated by trainees with senior author supervising
Blood loss in drain, pre and post op Hb, length of inpatient stay
and post operative complications were recorded in all cases.
Differences between the control group and those receiving
tranexamic acid were analysed using a Students T-test, with
p<0.05 taken as statistically significant.
Results: THR (comparing difference between tranexamic acid
group and control).
Mean drop in Hb was less in the tranexamic acid group p=0.019
Mean blood loss in drain was less in the tranexamic acid group
p=0.00039
Mean length of inpatient stay was less in the tranexamic acid
group p=0.012
Number of patients needing transfusion =4 in control group
compared to 0 in the tranexamic acid group
No of post operative P.E = 1 in tranexamic acid group compared
to 0 in the control group TKR (comparing difference between
tranexamic acid group and control).
Mean drop in Hb was less in the tranexamic acid group p=0.299
Mean blood loss in drain was less in the tranexamic acid group
p=0.00039
Mean length of inpatient stay was less in the tranexamic acid
group p=0.0124
No of patients needing transfusion =3 in control group compared
to 1 in the tranexamic acid group
Number of post operative P.E =2 in tranexamic acid group com-
pared to 0 in the control group
Conclusions: This study adds to the body of evidence which
supports the use of tranexamic acid in elective primary hip and
knee arthroplasty.
Statistically significant decreased blood loss in the drain when
administering tranexamic acid during THR and TKR
Statistically significant reduction in the Hb drop post operatively
when administering tranexamic acid during THR.
Clinically significant reduction in inpatient stay in those patients
who received tranexamic acid.
Results achieved despite variations in methodology to previous
studies and variation in surgical technique to previous studies.
Weaknesses of study is selection bias and limited sample size.
More research is required to determine optimum dose and timing
of administration.
The routine use of this antifibrinolytic should be considered for
patients undergoing elective primary THR and TKR.
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ABRASION ARTHROPLASTY WITH OSTEOTOMY FOR
MEDIAL COMPARTMENT OSTEOARTHRITIS OF THE
KNEE - A VIABLE ALTERNATIVE TO
UNICOMPARTMENTAL OR TOTAL KNEE JOINT
REPLACEMENT
J. Toft, A. Vilas-Boas
Alpha Klinik München, Munich, Germany
Purpose: The objective of this study is to demonstrate that
for medial compartment knee arthritis abrasion arthroplasty and
osteotomy can be a viable alternative to replacement surgery.
Methods: Between 1989 and 2002, 486 medial compartment
abrasion arthroplasties with valgus osteotomy were performed.
The Oxford Knee Questionnaire was sent to 470 patients, of
which 296 were correctly answered. All patients had grade III/IV
(Outerbridge) cartilage lesions.34 patients were bilateral. The
minimum follow-up was 12 months, and the maximum was 14,
4 years, which means an average of 2, 99 years. The abrasion
arthroplasty was performed with an abrader, combined with mi-
cro picks. The osteotomy was a closing-wedge osteotomy, with
proximal fibular lysis and internal fixation. All patients followed a
12-week non-weightbearing protocol.
Results: The mean knee score for patients treated by abrasion
arthroplasty and osteotomy was 38, 10 ± 8, 04. Of the 296
patients,133 (44.93%) had one or more surgeries before the
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abrasion arthroplasty, reaching a score of 38,18. The number
of surgeries varied from 1 to 10 before the proposed treatment.
It is evident that an increased number of previous surgeries
lowers the attained scores, although it is still higher than the
scores reported in the literature for TKR or UKR. In addition,
when analysed by follow-up groups, the results have a clear
tendency to become better with time, with the highest scores
reached by the patients with the longest follow-up. Although not
specifically asked by the questionnaire, 71 patients (23,98%)
added remarks concerning their sports activities such as cycling,
mountaineering, jogging, dancing, tennis, skiing and golf. Such
activities are obviously not anticipated following UKR or TKR
and that is why the Oxford Questionnaire does not include such
categories.
Conclusions: The vast majority of patients treated with the
abrasion/osteotomy combination are very satisfied over a period
of up to 15 years and only 2.5 percent of the patients received
a total knee replacement so that the procedure is indeed an
alternative to joint replacement. When compared to results for
TKR and UKR, our results are better, with fewer and less severe
complications. This treatment modality is particularly interesting
for young patients and for patients who refuse joint replacement
surgery.
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DOES MINIMAL INVASIVE THR SURGERY USING THE
ANTEROLATERAL APPROACH IS THE WAY TO GO?
R. Debi, Y. Bar Ziv, S. Efrati, N. Choen, R. Kardosh, D. Segal,
N. Halperin, G. Agar
Asaf Harofe Medical Center, Tel Aviv, Israel
Purpose: Total hip arthroplasty preformed with the use of mini-
mal incision surgery has received tremendous attention recently.
Various surgical approaches have been introduced to minimize
surgical trauma to the soft tissues. The mini invasive Modified
Watson-Jones approach have been selected to decrease the
perioperative complications associated with other mini invasive
approaches that has been described. The anterolateral mini in-
cision is a new innovative approach using the intramuscular plan
between the gluteus medius and the tensor fascia lata. This
intermuscular interval through a small incision provides good
exposure and preserves muscle integrity. Moreover, preserving
the muscle integrity provides a very stable joint after implanta-
tion such that no restrictions is giving to the patient during the
rehabilitation period.
Methods: Between July 2004 to September 2005, we used this
approach on 60 sequential patients. Fifty patients were enrolled
in this prospective study. Patients were evaluated preopera-
tively, immediately postoperatively, and at 3-month and 6 month
follow-up according to operating time, intraoperative blood loss,
subcutaneous drains blood loss, post op pain control drugs re-
quirements, short form 36 patient questionnaire (SF-36) scores
and the Harris Hip Score (HHS). 4 patients had previous THA on
the contralteral side.
Results: The average operation time was 137min (range 90-
200min), there were no readmissions, no dislocations, the mean
post operation blood transfusion requirements was 1.64, the
mean subcutaneous drains blood loss was 241.9ml (range 20-
620ml), there was significant improvement in function, pain,
SF-36 and Harris Hip Score (HHS) at the 3-month and 6-month
follow-up examination. The average length of the incision was
under 12cm. We had one reoperation due to deep infection.
All four patients with bilateral THA preferred their last operation
due to the lack of restrictions and the faster recovery of muscle
strength.
Conclusions: We think that using mini invasive Modified
Watson-Jones approach in total hip replacement surgeries is
a preferable option. There are several advantages of using this
approach compared with the more traditional techniques. Such
a technique should help reduce morbidity and complication rates
for those patients undergoing a total hip replacement.
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LUBRICIN BIOSYNTHESIS BY CHONDROCYTES AND
SYNOVIOCYTES IS DIFFERENTIALLY REGULATED BY
CYTOKINES/GROWTH FACTORS
A.R. Jones, C.R. Flannery
Wyeth Research, Cambridge, MA
Purpose: Lubricin, also commonly referred to as superficial zone
protein (SZP) and proteoglycan 4 (PRG4) is a mucinous sialogly-
coprotein required for critical boundary lubrication at interfacing
surfaces of cartilage and other joint tissues such as tendon and
meniscus, enabling low friction levels between interfacing joint
tissues. The aim of this study was to investigate alterations in
lubricin mRNA and protein expression after the exposure of hu-
man chondrocytes and synoviocytes to anabolic and catabolic
mediators.
Methods: Human articular chondrocytes and synoviocytes iso-
lated from normal (non-OA) tissues, cultured in monolayer and
stimulated with cytokines/growth factors. Lubricin mRNA lev-
els were assessed after 24 hours by quantitative RT-PCR
(qPCR), and were normalized to GAPDH levels. Human chon-
drocyte/synoviocyte conditioned media were harvested after 48
hours and analyzed by Western blotting with anti-lubricin anti-
bodies.
Results: Treatment of human chondrocytes and synoviocytes
with the pro-inflammatory cytokine IL-1 beta resulted in reduced
expression of lubricin mRNA (∼40% of control levels), and similar
changes in lubricin protein levels were observed by Western
blotting. A ∼6-fold increase in lubricin mRNA was observed
after TGF-beta treatment of chondrocytes and synoviocytes.
Chondrocytes displayed an upregulation of lubricin biosynthesis
in response to oncostatin M (OSM), and diminished levels after
treatment with TNF-alpha. This was in contrast to synoviocytes,
which did not respond significantly to OSM or TNF-alpha.
